Clinical Efficacy and Safety of Psoriasis Treatments in Patients with Concomitant Metabolic Syndrome: A Narrative Review Joseph F. MerolaArthur KavanaughJashin J. Wu Review Open access 25 August 2022 Pages: 2201 - 2216
Polyaphron Dispersion Technology, A Novel Topical Formulation and Delivery System Combining Drug Penetration, Local Tolerability and Convenience of Application Morten PraestegaardFraser SteeleNigel Crutchley Review Open access 01 September 2022 Pages: 2217 - 2231
Comorbidities in Androgenetic Alopecia: A Comprehensive Review Shuang ChenXiaohang XieYong Zhang Review Open access 17 September 2022 Pages: 2233 - 2247
Dermatologic Disease-Directed Targeted Therapy (D3T2): The Application of Biomarker-Based Precision Medicine for the Personalized Treatment of Skin Conditions—Precision Dermatology Philip R. CohenRazelle Kurzrock Review Open access 19 September 2022 Pages: 2249 - 2271
Mindfulness and Meditation for Psoriasis: A Systematic Review Erin BartholomewMimi ChungWilson Liao Review Open access 14 September 2022 Pages: 2273 - 2283
Botulinum Toxin A Alleviates Persistent Erythema and Flushing in Patients with Erythema Telangiectasia Rosacea Rongli YangChang LiuXin Mu Original Research Open access 04 August 2022 Pages: 2285 - 2294
Correction to: Botulinum Toxin A Alleviates Persistent Erythema and Flushing in Patients with Erythema Telangiectasia Rosacea Rongli YangChang LiuXin Mu Correction Open access 13 September 2022 Pages: 2295 - 2295
Maskne—Dermatosis of a Pandemic. A Survey on the Impact of PPE on Facial Skin Among HCW and N-HCW in Poland Izabela U. MalczynskaGabriela KrychIwona Flisiak Original Research Open access 01 September 2022 Pages: 2297 - 2308
Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective Study Luigi GargiuloLuciano IbbaAlessandra Narcisi Original Research Open access 05 September 2022 Pages: 2309 - 2324
Efficacy of Tildrakizumab Across Different Body Weights in Moderate-to-Severe Psoriasis Over 5 Years: Pooled Analyses from the reSURFACE Pivotal Studies Diamant ThaçiSascha GerdesLluís Puig Original Research Open access 13 September 2022 Pages: 2325 - 2341
A Retrospective Real-World Study of the Effectiveness and Tolerability of Tildrakizumab in UK Adults with Moderate-to-Severe Chronic Plaque Psoriasis Gabrielle BecherSophia ConnerIsmail Kasujee Original Research Open access 09 September 2022 Pages: 2343 - 2354
A Cross-Sectional Study on Factors Affecting the Decision to Conduct Dermatologic Surgery Procedures During the COVID-19 Pandemic Rungsima WanitphakdeedechaTatre JantarakolicaKrisinda Clare C. Dim-Jamora Original Research Open access 16 September 2022 Pages: 2355 - 2369
Can Microneedle Fractional Radiofrequency System Treatment Impair the Skin Barrier Function in Chinese Patients? A Prospective Clinical Trial Xiujuan WuZhen ZhangZongfeng Zhao Original Research Open access 21 September 2022 Pages: 2371 - 2382
Release of Cervical Muscle Tension Improves Psychological Stress and Symptoms of Moderate-to-Severe Atopic Dermatitis: a Case Series with 20 Patients Shusaku HosonoKoji FujitaKeiichi Akita Brief Report Open access 21 September 2022 Pages: 2383 - 2395